Answer
Cinqaero (reslizumab) contains 0.05 mmol (1.15 mg) of sodium per 2.5 mL vial and 0.20 mmol (4.6 mg) per 10 mL vial.
Sources for this answer
- Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusionTeva Pharmaceuticals Ltd · emc · SmPC §2 Qualitative and quantitative composition · Version 8Document updated
Sources checked